Equities analysts expect Rewalk Robotics Ltd (NASDAQ:RWLK) to post earnings of ($0.31) per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Rewalk Robotics’ earnings, with the lowest EPS estimate coming in at ($0.39) and the highest estimate coming in at ($0.22). Rewalk Robotics reported earnings of ($0.47) per share during the same quarter last year, which suggests a positive year over year growth rate of 34%. The business is scheduled to report its next earnings results on Friday, February 16th.

On average, analysts expect that Rewalk Robotics will report full year earnings of ($1.11) per share for the current financial year, with EPS estimates ranging from ($1.22) to ($1.00). For the next fiscal year, analysts forecast that the company will report earnings of ($1.26) per share, with EPS estimates ranging from ($1.27) to ($1.24). Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Rewalk Robotics.

Rewalk Robotics (NASDAQ:RWLK) last released its quarterly earnings data on Thursday, November 2nd. The medical device company reported ($0.22) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.32) by $0.10. The firm had revenue of $1.70 million for the quarter, compared to the consensus estimate of $1.63 million. Rewalk Robotics had a negative return on equity of 568.25% and a negative net margin of 346.14%. The company’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.62) earnings per share.

A number of brokerages recently issued reports on RWLK. Zacks Investment Research upgraded Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a report on Thursday, November 9th. Canaccord Genuity restated a “buy” rating and set a $3.00 price target on shares of Rewalk Robotics in a report on Monday, November 6th. Oppenheimer set a $3.00 price target on Rewalk Robotics and gave the company a “buy” rating in a report on Tuesday, December 26th. Jefferies Group reduced their price target on Rewalk Robotics from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 3rd. Finally, Piper Jaffray Companies restated a “buy” rating and set a $3.00 price target on shares of Rewalk Robotics in a report on Sunday, January 7th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $2.83.

An institutional investor recently raised its position in Rewalk Robotics stock. Essex Investment Management Co. LLC boosted its holdings in shares of Rewalk Robotics Ltd (NASDAQ:RWLK) by 328.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 156,981 shares of the medical device company’s stock after purchasing an additional 120,362 shares during the period. Essex Investment Management Co. LLC owned about 0.72% of Rewalk Robotics worth $228,000 at the end of the most recent reporting period. 3.23% of the stock is currently owned by hedge funds and other institutional investors.

Rewalk Robotics (NASDAQ:RWLK) opened at $1.10 on Tuesday. The company has a market capitalization of $31.82, a PE ratio of -0.69 and a beta of 0.79. The company has a quick ratio of 1.65, a current ratio of 2.02 and a debt-to-equity ratio of 7.46. Rewalk Robotics has a twelve month low of $1.05 and a twelve month high of $3.20.

COPYRIGHT VIOLATION NOTICE: “-$0.31 Earnings Per Share Expected for Rewalk Robotics Ltd (RWLK) This Quarter” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/01/16/0-31-earnings-per-share-expected-for-rewalk-robotics-ltd-rwlk-this-quarter.html.

Rewalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Get a free copy of the Zacks research report on Rewalk Robotics (RWLK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.